Dupilumab treatment for up to 5 years improves clinical signs across all anatomical regions in adults with moderate-to-severe atopic dermatitis

L. A. Beck, R. Bissonnette, M. Deleuran,T. Nakahara, R. Galus,Z. Chen, E. Avetisova, A. Dubost-Brama, A. Shabbir

Journal of Investigative Dermatology(2023)

引用 0|浏览2
暂无评分
关键词
atopic dermatitis,dupilumab treatment,moderate-to-severe
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要